~ Bags Three Hundred Thousand Naira

LAGOS: The Faculty of Pharmacy, Chukwuemeka Odumegwu Ojukwu University represented by Miss Chizoba Vivian Ihediuche on Thursday 21st March 2024 emerged 3rd in the 2024 Shalina Young Talent Awards.

The Shalina Young Talent Awards (SYTA) is a yearly and highly contested national quiz competition organized by Shalina Healthcare Nigeria, a multinational Pharmaceutical Company. It is for FINAL YEAR Pharmacy Students in all the 24 accredited Pharmacy Schools in Nigeria.

The competition has two stages, Local and National. The 2024 local competition was held in January 2024 at the Faculty of Pharmaceutical Sciences, Chukwuemeka Odumegwu Ojukwu University where Miss. Vivian Chizoba Ihediuche emerged first and was billed to represent the University at the National Level.

ALSO READ  Breaking: Mobile courts convict 874 lockdown violators

The competition which was held in NECA House, Ikeja, Lagos, comprised multiple choice questions, oral presentation, ability to choose a question and answer immediately (rapid fire), and clinical case questions. Out of 24 contestants, COOU made it to the last five and eventually made it to the third position in the final round coming behind the University of Lagos, and the University of Jos.

Speaking to COOUNewS, the Dean, of the Faculty of Pharmaceutical Sciences, Prof. Theophine Akunne thanked the organizers of the competition for ensuring transparency in the entire process. He stated that COOU is participating in the competition for the first time and would do its best to emerge first come 2025

ALSO READ  Chimamanda Adichie attacks catholic church, calls them hungry community

Prof. Moji Adeyeye, Director General of NAFDAC; Pharm. Ahmed Babashehu, Registrar, Pharmacy Council of Nigeria; Prof. Cyril Usifo, National President, Pharmaceutical Society of Nigeria, and the MD Shalina Healthcare Nig., among others were present at the occasion.

©COOUNewS 2024!

What are your thoughts?

Discover more from Odogwu Blog

Subscribe now to keep reading and get access to the full archive.

Continue reading